US Patent 11187697 Substrate clearance assays for lysosomal enzymes
Patent 11187697 was granted and assigned to Takeda Pharmaceutical Company on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+411 characters)
Article
Patent abstract
The present invention provides, among other things, improved substrate clearance assays for lysosomal enzyme that are particularly useful for measuring potency of lysosomal enzymes or other therapeutics for treatment of lysosomal storage diseases. In particular, the present invention combines a physiologically relevant substrate cell assay and an efficient scintillation based detection method.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Vijay Chhajlani0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111876970
Date of Patent
November 30, 2021
0Patent Application Number
151193240
Date Filed
February 18, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11187697 Substrate clearance assays for lysosomal enzymes
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11187697
Date of patent
November 30, 2021
Patent application number
15119324
Date Filed
February 18, 2015
Patent primary examiner
Find more entities like US Patent 11187697 Substrate clearance assays for lysosomal enzymes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.